Health Care & Life Sciences » Pharmaceuticals | Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd.

Mayne Pharma Group Ltd.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$605.95 M
Shares Outstanding
1.57 B
Public Float
-
Mayne Pharma Group Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.03
Market Cap
AUD846.87 M
Shares Outstanding
1.58 B
Public Float
1.35 B

Profile

Address
1538 Main North Road
Salisbury South Australia (SA) 5106
Australia
Employees -
Website http://www.maynepharma.com
Updated 07/08/2019
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products.

Financials

View All

Scott Richards
Chief Executive Officer, Executive Director & MD
Patrick J. Blake
Director